Zoonogen

ZOONOGEN was founded in 2015 in Beijing and established its branch in Guangzhou. The company specialized in discovering high quality of monoclonal antibody using proprietary antibody platform. Based on strong scientific foundation, Zoonogen provides best in the world of antibodies to IVD & medication industries, as well as research community. Our antibodies mainly target to the biomarkers are related to infectious diseases, oncologic as well as metabolisic indications. The ultimate aim of Zoonogen is to generate world-class bio-reagents and therapeutics for human health. Our catalogue currently covers recombinant antigen, monoclonal and polyclonal antibodies, ELISA kits as well as other reagents for the immunological diagnostic use.